Novo Seeds

https://www.novo.dk/seeds/

Novo A/S is the holding company of the Novo Group, and is wholly owned by the Novo Nordisk Foundation. Novo A/S was established in 1999 to manage the assets of the Foundation and actively make investments on behalf of the Foundation. Novo A/S is not a corporate strategic fund; Novo A/S invests for financial rather than strategic returns. Novo A/S is active in both Europe and North America. The Novo A/S venture investments are managed by a team of four Partners in Copenhagen, one in London and three in San Francisco. With an evergreen structure, Novo A/S annually invests approximately EUR 200 million through Novo Ventures, Novo Seeds, and Novo Growth Equity. In total Novo A/S has more than EUR 15 billion under management, which includes significant shareholdings in the independently operating and publicly listed companies Novo Nordisk A/S and Novozymes A/S. *

	Start	2011-05-03 existent
	Group	Novo Group (Group)
	Industry	venture capital
	Industry 2	LIFE SCIENCES
	Person	Christgau, Stephan (Eir Ventures 202007– before Novo Seeds + Osteologix)
	Person 2	Grotkjær, Thomas (Novo Group 201809 Principal at Novo Seeds)

	Region	Hellerup
	Country	Denmark
	Street	19 Tuborg Havnevej c/o Novo A/S
	City	2900 Hellerup
	Tel	+45-3527-6500
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for ï¿½About Sectionï¿½: Delenex Therapeutics AG. (5/3/11). "Press Release: Delenex Extends Its A Round to CHF 30.2 Million. Thomas Dyrberg from Novo A/S Joins the Board of Directors". Schlieren.

		Record changed: 2020-12-16